These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4767492)

  • 1. [Release of a solid, easily soluble compound from the hydrophobic tablet matrix influenced by surface-active agents].
    Schekerdschijski R; Minkov E; Guschev A; Trandafilov T
    Pharmazie; 1973 Jul; 28(7):450-2. PubMed ID: 4767492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Release of an easily soluble drug from a hydrophobic tablet matrix].
    Schekerdjiski R; Trandafilov T
    Pharmazie; 1972 Sep; 27(9):586-8. PubMed ID: 5086355
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Release insoluble drugs from the hydrophobic tablet matrix. 2. Influence of non-ionogenic surface-active substances].
    Schekerdjiski R; Minkov E; Mihailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):635-6. PubMed ID: 5149135
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of auxillary substances on the release of hard-to-solve drugs from a hydrophobic tablet matrix].
    Schekerdjiski R; Trandafiloff A; Trandafiloff T
    Pharmazie; 1972 Mar; 27(3):167-8. PubMed ID: 4340367
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
    Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
    Lee KR; Kim EJ; Seo SW; Choi HK
    Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adaptation of an automatic method of the dosage control in vitro of the delayed-action preparations].
    Jeannin C; Morel C; Verain A
    J Pharm Belg; 1970; 25(6):529-39. PubMed ID: 5504099
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained release of highly water-soluble drugs with micelle forming ability from polyionic matrix tablets.
    Tanaka Y; Miyazaki Y; Yakou S; Takayama K
    Pharmazie; 2007 Jan; 62(1):41-5. PubMed ID: 17294812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Release insoluble drugs from the hydrophobic tablet matrix. 1].
    Schekerdjiski R; Trandafilov A; Michailova D; Trandafilov T
    Pharmazie; 1971 Oct; 26(10):632-4. PubMed ID: 5149134
    [No Abstract]   [Full Text] [Related]  

  • 18. Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings.
    Cao QR; Kim TW; Lee BJ
    Int J Pharm; 2007 Jul; 339(1-2):19-24. PubMed ID: 17532156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of amphoteric tensides on the pharmaceutic availability of model drugs according to formulation].
    Bialik W; Kuferska E; Jaworski E
    Acta Pol Pharm; 1992; 49(1-2):21-3. PubMed ID: 8769076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system.
    Yang L; Fassihi R
    J Pharm Pharmacol; 2003 Oct; 55(10):1331-7. PubMed ID: 14607013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.